ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Lung cancer

July 29, 2025
This video demonstrates the successful management of a challenging case of a centrally located left upper lobe tumor through a minimally invasive bronchial sleeve lobectomy, which led to excellent outcomes.
July 16, 2025
This article presents a large, population-based study using UK primary care data to identify comorbid conditions associated with lung cancer in never-smokers (LCINS).
July 11, 2025
At the Society for Cardiothoracic Surgery in Great Britain and Ireland Annual Meeting, leading surgeons presented on the management of early-stage lung cancer.
July 8, 2025
This video demonstrates a standardized robotic segmentectomy using the French lobectomy technique, structured in five anatomical zones. It highlights the integration of 3D reconstruction and mixed reality planning in the surgical management of a left basal pyramid lesion in a 76-year-old patient.
June 26, 2025
This study evaluated the effect of perioperative invasive nodal staging on nodal upstaging in early-stage non-small cell lung cancer (NSCLC) patients undergoing resection.
June 24, 2025
This video demonstrates a low-cost method for implementing augmented reality in robotic segmentectomy using open-source software and affordable hardware.
May 22, 2025
This retrospective study examined whether following intraoperative lymph node sampling guidelines influenced overall survival and nodal upstaging in patients with non-small cell lung cancer (NSCLC) who underwent lung resection in Denmark from 2012 to 2021.
May 22, 2025
This research developed a deep learning algorithm to predict pathological pleural invasion (pPL) from thoracoscopic imagery in patients with cT1 tumors receiving sublobar resections. The study included 80 patients, with the learning model trained on 64 cases and validated on 16.
May 1, 2025
Extended sleeve lobectomy (ESL) is considered a lung-sparing alternative to pneumonectomy (PN) for centrally located non-small cell lung cancer (NSCLC) when standard sleeve lobectomy (SSL) is not feasible. This retrospective study analyzed 94 patients who received neoadjuvant immunochemotherapy followed by either PN, ESL, or SSL.
May 1, 2025
The recent CheckMate 816 trial indicated that neoadjuvant chemo-immunotherapy provided limited local control in stage II–III resectable non-small cell lung cancer (NSCLC).

Pages